CDXS
Price
$1.28
Change
-$0.04 (-3.03%)
Updated
Feb 5, 02:33 PM (EDT)
Capitalization
119.23M
21 days until earnings call
Intraday BUY SELL Signals
TPST
Price
$2.27
Change
-$0.10 (-4.20%)
Updated
Feb 5, 03:52 PM (EDT)
Capitalization
11.73M
Intraday BUY SELL Signals
Interact to see
Advertisement

CDXS vs TPST

Header iconCDXS vs TPST Comparison
Open Charts CDXS vs TPSTBanner chart's image
Codexis
Price$1.28
Change-$0.04 (-3.03%)
Volume$1.07K
Capitalization119.23M
Tempest Therapeutics
Price$2.27
Change-$0.10 (-4.20%)
Volume$100
Capitalization11.73M
CDXS vs TPST Comparison Chart in %
CDXS
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CDXS vs. TPST commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a Hold and TPST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CDXS: $1.32 vs. TPST: $2.38)
Brand notoriety: CDXS and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 146% vs. TPST: 1044%
Market capitalization -- CDXS: $119.23M vs. TPST: $11.73M
CDXS [@Biotechnology] is valued at $119.23M. TPST’s [@Biotechnology] market capitalization is $11.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • CDXS’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, both CDXS and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • CDXS’s TA Score: 4 bullish, 6 bearish.
  • TPST’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, TPST is a better buy in the short-term than CDXS.

Price Growth

CDXS (@Biotechnology) experienced а +2.33% price change this week, while TPST (@Biotechnology) price change was -14.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

CDXS is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDXS($119M) has a higher market cap than TPST($11.7M). TPST YTD gains are higher at: -17.073 vs. CDXS (-19.018). TPST has higher annual earnings (EBITDA): -35.35M vs. CDXS (-55.32M). CDXS has more cash in the bank: 58.7M vs. TPST (7.51M). TPST has less debt than CDXS: TPST (8.41M) vs CDXS (68.6M). CDXS has higher revenues than TPST: CDXS (52.9M) vs TPST (0).
CDXSTPSTCDXS / TPST
Capitalization119M11.7M1,017%
EBITDA-55.32M-35.35M156%
Gain YTD-19.018-17.073111%
P/E RatioN/AN/A-
Revenue52.9M0-
Total Cash58.7M7.51M781%
Total Debt68.6M8.41M816%
FUNDAMENTALS RATINGS
CDXS vs TPST: Fundamental Ratings
CDXS
TPST
OUTLOOK RATING
1..100
5575
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9196
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDXS's Valuation (28) in the Chemicals Specialty industry is in the same range as TPST (37) in the Pharmaceuticals Major industry. This means that CDXS’s stock grew similarly to TPST’s over the last 12 months.

CDXS's Profit vs Risk Rating (100) in the Chemicals Specialty industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that CDXS’s stock grew similarly to TPST’s over the last 12 months.

CDXS's SMR Rating (99) in the Chemicals Specialty industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that CDXS’s stock grew similarly to TPST’s over the last 12 months.

CDXS's Price Growth Rating (91) in the Chemicals Specialty industry is in the same range as TPST (96) in the Pharmaceuticals Major industry. This means that CDXS’s stock grew similarly to TPST’s over the last 12 months.

TPST's P/E Growth Rating (88) in the Pharmaceuticals Major industry is in the same range as CDXS (100) in the Chemicals Specialty industry. This means that TPST’s stock grew similarly to CDXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDXSTPST
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
82%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CDXS
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GENK2.100.06
+2.94%
GEN Restaurant Group
AB42.451.09
+2.64%
AllianceBernstein Holding LP
CHT41.77-0.07
-0.17%
CHUNGHWA TELECOM CO Ltd
SENEA118.21-1.42
-1.19%
Seneca Foods Corp
LUCD1.20-0.05
-4.00%
Lucid Diagnostics

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been closely correlated with LENZ. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDXS jumps, then LENZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
-2.94%
LENZ - CDXS
68%
Closely correlated
-5.86%
RZLT - CDXS
66%
Closely correlated
-7.62%
MREO - CDXS
66%
Closely correlated
-2.73%
TPST - CDXS
66%
Loosely correlated
-1.24%
KRRO - CDXS
65%
Loosely correlated
-3.46%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been closely correlated with VTGN. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if TPST jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-1.24%
VTGN - TPST
87%
Closely correlated
-3.20%
QNCX - TPST
84%
Closely correlated
+9.28%
MREO - TPST
84%
Closely correlated
-2.73%
BCAB - TPST
80%
Closely correlated
+11.06%
ARCT - TPST
79%
Closely correlated
+0.14%
More